Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance.

Chen, L., Wang, C., Sun, H., Wang, J., Liang, Y., Wang, Y., & Wong, G. (2021). The bioinformatics toolbox for circRNA discovery and analysis. Briefings in Bioinformatics, 22(2), 1706–28.

pubmed: 32103237 doi: 10.1093/bib/bbaa001

Jeck, W. R., & Sharpless, N. E. (2014). Detecting and characterizing circular RNAs. Nature Biotechnology, 32(5), 453–461.

pubmed: 24811520 pmcid: 4121655 doi: 10.1038/nbt.2890

Chen, C. Y., & Sarnow, P. (1995). Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science, 268(5209), 415–417.

pubmed: 7536344 doi: 10.1126/science.7536344

Sanger, H. L., et al. (1976). Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proceedings of the National Academy of Sciences of the United States of America, 73(11), 3852–3856.

pubmed: 1069269 pmcid: 431239 doi: 10.1073/pnas.73.11.3852

Hsu, M. T., & Coca-Prados, M. (1979). Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature, 280(5720), 339–340.

pubmed: 460409 doi: 10.1038/280339a0

Patop, I. L., Wüst, S., & Kadener, S. (2019). Past, present, and future of circRNAs. The EMBO Journal, 38(16), e100836.

pubmed: 31343080 pmcid: 6694216 doi: 10.15252/embj.2018100836

Cocquerelle, C., et al. (1993). Mis-splicing yields circular RNA molecules. The FASEB Journal, 7(1), 155–160.

pubmed: 7678559 doi: 10.1096/fasebj.7.1.7678559

Salzman, J., Gawad, C., Wang, P. L., Lacayo, N., & Brown, P. O. (2012, Feb 1). Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PloS One, 7(2), e30733.

pubmed: 22319583 pmcid: 3270023 doi: 10.1371/journal.pone.0030733

Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., & Loewer, A. (2013, Mar 21). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495(7441), 333–338.

pubmed: 23446348 doi: 10.1038/nature11928

Ivanov, A., Memczak, S., Wyler, E., Torti, F., Porath, H. T., Orejuela, M. R., Piechotta, M., Levanon, E. Y., Landthaler, M., Dieterich, C., & Rajewsky, N. (2015, Jan 13). Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Reports, 10(2), 170–177.

pubmed: 25558066 doi: 10.1016/j.celrep.2014.12.019

Ye, C. Y., Chen, L., Liu, C., Zhu, Q. H., & Fan, L. (2015, Oct). Widespread noncoding circular RNA s in plants. New Phytologist, 208(1), 88–95.

pubmed: 26204923 doi: 10.1111/nph.13585

Danan, M., Schwartz, S., Edelheit, S., & Sorek, R. (2012, Apr 1). Transcriptome-wide discovery of circular RNAs in Archaea. Nucleic Acids Research, 40(7), 3131–3142.

pubmed: 22140119 doi: 10.1093/nar/gkr1009

Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014, Oct 2). circRNA biogenesis competes with pre-mRNA splicing. Molecular Cell, 56(1), 55–66.

pubmed: 25242144 doi: 10.1016/j.molcel.2014.08.019

Li, X., Yang, L., & Chen, L. L. (2018). The biogenesis, functions, and challenges of circular RNAs. Molecular Cell, 71(3), 428–442.

pubmed: 30057200 doi: 10.1016/j.molcel.2018.06.034

Zhang, X. O., et al. (2014). Complementary sequence-mediated exon circularization. Cell, 159(1), 134–147.

pubmed: 25242744 doi: 10.1016/j.cell.2014.09.001

Sha, J., et al. (2016). Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling. Biomedicine & Pharmacotherapy, 84, 177–184.

doi: 10.1016/j.biopha.2016.09.037

Zhang, Y., et al. (2013). Circular intronic long noncoding RNAs. Molecular Cell, 51(6), 792–806.

pubmed: 24035497 doi: 10.1016/j.molcel.2013.08.017

Li, Z., Huang, C., Bao, C., Chen, L., Lin, M., Wang, X., Zhong, G., Yu, B., Hu, W., Dai, L., & Zhu, P. (2015). Exon-intron circular RNAs regulate transcription in the nucleus. Nature Structural & Molecular Biology, 22(3), 256–264.

doi: 10.1038/nsmb.2959

Zhang, M., Bai, X., Zeng, X., Liu, J., Liu, F., & Zhang, Z. (2021, Dec). circRNA-miRNA-mRNA in breast cancer. Clinica Chimica Acta, 1(523), 120–130.

doi: 10.1016/j.cca.2021.09.013

Mirzaei, S., Gholami, M. H., Hushmandi, K., Hashemi, F., Zabolian, A., Canadas, I., Zarrabi, A., Nabavi, N., Aref, A. R., Crea, F., & Wang, Y. (2022, Mar 2). The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of Hematology & Oncology, 15(1), 18.

doi: 10.1186/s13045-022-01235-1

Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Ranjbar, A., Saleh, S. H., Bagherian, M., & Sharifzadeh, S. O., Hushmandi K, Liskova A. (2021, Jul). Regulation of nuclear factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? Cancer Letters, 1(509), 63–80.

doi: 10.1016/j.canlet.2021.03.025

Yuan, G., et al. (2021). Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance. Bioengineered, 12(1), 4936–4945.

pubmed: 34374630 pmcid: 8806414 doi: 10.1080/21655979.2021.1960769

Wong, C. H., et al. (2022). CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein. Molecular Cancer, 21(1), 10.

pubmed: 34983537 pmcid: 8725379 doi: 10.1186/s12943-021-01481-w

Ju, Y., et al. (2021). CircRNA ANXA2 promotes lung cancer proliferation and metastasis by upregulating PDPK1 expression. Journal of Oncology, 2021, 4526609.

pubmed: 34992655 pmcid: 8727169 doi: 10.1155/2021/4526609

Huang, X. Y., et al. (2020). Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. Journal of Experimental & Clinical Cancer Research, 39(1), 20.

doi: 10.1186/s13046-020-1529-9

Tan, L., Huang, Z., Chen, Z., Chen, S., Ye, Y., Chen, T., & Chen, Z. (2023, Jan 2). CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair. Journal of Chemotherapy, 35(1), 11–18.

pubmed: 34927575 doi: 10.1080/1120009X.2021.2009990

Xu, J., et al. (2020). CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduction and Targeted Therapy, 5(1), 298.

pubmed: 33361760 pmcid: 7762756 doi: 10.1038/s41392-020-00375-5

Wang, H., et al. (2019). CircRNA circ_0067934 overexpression correlates with poor prognosis and promotes thyroid carcinoma progression. Medical Science Monitor, 25, 1342–1349.

pubmed: 30779728 pmcid: 6390454 doi: 10.12659/MSM.913463

Zhang, S., et al. (2019). CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124. Journal of BUON, 24(6), 2402–2410.

pubmed: 31983112

Peng, Q. S., et al. (2020). circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. Cell Death & Disease, 11(2), 112.

doi: 10.1038/s41419-020-2273-y

Zhang, X., et al. (2018). circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma. Cell Death & Disease, 9(11), 1091.

doi: 10.1038/s41419-018-1132-6

Su, Y., et al. (2019). CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY), 11(19), 8183–8203.

pubmed: 31581132 doi: 10.18632/aging.102312

Liu, Z., et al. (2019). CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death & Disease, 10(12), 900.

doi: 10.1038/s41419-019-2089-9

Li, C., et al. (2021). CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Diagnostic Pathology, 16(1), 93.

pubmed: 34689819 pmcid: 8543861 doi: 10.1186/s13000-021-01153-9

Yang, L., Zou, X., Zou, J., & Zhang, G. (2021, May 1). Functions of circular RNAs in bladder, prostate and renal cell cancer. Molecular Medicine Reports, 23(5), 1–2.

doi: 10.3892/mmr.2021.11946

Osca-Verdegal, R., et al. (2022). Use of circular RNAs in diagnosis, prognosis and therapeutics of renal cell carcinoma. Frontiers in Cell and Development Biology, 10, 879814.

doi: 10.3389/fcell.2022.879814

Cai, Z., & Li, H. (2020). Circular RNAs and bladder cancer. Oncotargets and Therapy, 13, 9573–9586.

pubmed: 33061440 pmcid: 7535116 doi: 10.2147/OTT.S268859

Liu, X., et al. (2021). Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance. Molecular Therapy--Nucleic Acids, 26, 1130–1147.

pubmed: 34820150 pmcid: 8585584 doi: 10.1016/j.omtn.2021.10.017

Chao, F., et al. (2021). The emerging role of circular RNAs in prostate cancer: A systematic review. Frontiers in Cell and Development Biology, 9, 681163.

doi: 10.3389/fcell.2021.681163

Zhang, Z. H., et al. (2023). The function and mechanisms of action of circular RNAs in Urologic Cancer. Molecular Cancer, 22(1), 61.

pubmed: 36966306 pmcid: 10039696 doi: 10.1186/s12943-023-01766-2

Taheri, M., et al. (2021). The role and clinical potentials of circular RNAs in prostate cancer. Frontiers in Oncology, 11, 781414.

pubmed: 34804984 pmcid: 8604184 doi: 10.3389/fonc.2021.781414

Pettenati, C., & Ingersoll, M. A. (2018). Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nature Reviews Urology, 15(10), 615–625.

pubmed: 29991725 doi: 10.1038/s41585-018-0055-4

Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017, Jan 1). Bladder cancer incidence and mortality: A global overview and recent trends. European Urology, 71(1), 96–108.

pubmed: 27370177 doi: 10.1016/j.eururo.2016.06.010

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., Forman, D., & Bray, F. (2013, Apr 1). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 1374–1403.

pubmed: 23485231 doi: 10.1016/j.ejca.2012.12.027

Robertson, A. G., Kim, J., Al-Ahmadie, H., Bellmunt, J., Guo, G., Cherniack, A. D., Hinoue, T., Laird, P. W., Hoadley, K. A., Akbani, R., & Castro, M. A. (2017, Oct 19). Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell, 171(3), 540–556.

pubmed: 28988769 pmcid: 5687509 doi: 10.1016/j.cell.2017.09.007

Cancer Genome Atlas Research Network. (2014). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature, 507(7492), 315.

doi: 10.1038/nature12965

Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., & Kim, W. Y. (2014, Feb 25). Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proceedings of the National Academy of Sciences, 111(8), 3110–3115.

doi: 10.1073/pnas.1318376111

Sjödahl, G., Lövgren, K., Lauss, M., Patschan, O., Gudjonsson, S., Chebil, G., Aine, M., Eriksson, P., Månsson, W., Lindgren, D., & Fernö, M. (2013, Sep 1). Toward a molecular pathologic classification of urothelial carcinoma. The American Journal of Pathology, 183(3), 681–691.

pubmed: 23827819 doi: 10.1016/j.ajpath.2013.05.013

Yang, X., et al. (2021). Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer. Molecular Cancer, 20(1), 4.

pubmed: 33397425 pmcid: 7780637 doi: 10.1186/s12943-020-01300-8

Rosenberg, J. E., Hoffman-Censits, J., Powles, T., Van Der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., & Srinivas, S. (2016, May 7). Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial. The Lancet, 387(10031), 1909–1920.

doi: 10.1016/S0140-6736(16)00561-4

Flaig, T. W., et al. (2017). Proceedings of the 3rd Annual Albert Institute for Bladder Cancer. Research Symposium, 3(3), 211–223.

Sanli, O., et al. (2017). Bladder cancer, 3(1), 1–19.

doi: 10.3233/BLC-160073

Plimack, E. R., et al. (2017). Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): A non-randomised, open-label, phase 1b study, 18(2), 212–220.

Ashrafizadeh, M., Zarrabi, A., Karimi-Maleh, H., Taheriazam, A., Mirzaei, S., Hashemi, M., Hushmandi, K., Makvandi, P., Nazarzadeh Zare, E., Sharifi, E., & Goel, A. (2023, Jan). (Nano) platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering & Translational Medicine, 8(1), e10353.

doi: 10.1002/btm2.10353

Kirkali, Z., et al. (2005). Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology, 66(6, Supplement 1), 4–34.

pubmed: 16399414 doi: 10.1016/j.urology.2005.07.062

Wang, G., et al. (2022). NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clinical and Translational Medicine, 12(5), e738.

pubmed: 35522942 pmcid: 9076013 doi: 10.1002/ctm2.738

Yang, Y., et al. (2022). Prognostic analysis of differentially expressed DNA damage repair genes in bladder cancer. Pathology Oncology Research, 28, 1610267.

pubmed: 35685866 pmcid: 9172279 doi: 10.3389/pore.2022.1610267

Wu, J., et al. (2021). Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin-dependent-like kinase 5. Journal of Pineal Research, 71(3), e12765.

pubmed: 34487576 doi: 10.1111/jpi.12765

Zhang, Y., et al. (2021). Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells. Aging (Albany NY), 13(17), 21251–21267.

pubmed: 34510030 doi: 10.18632/aging.203441

Shen, L., et al. (2022). PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer. International Journal of Biological Sciences, 18(14), 5459–5474.

pubmed: 36147463 pmcid: 9461664 doi: 10.7150/ijbs.74546

Song, Q., et al. (2022). Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. Journal of Translational Medicine, 20(1), 308.

pubmed: 35794606 pmcid: 9258227 doi: 10.1186/s12967-022-03508-2

Jing, W., et al. (2022). FGFR3 destabilizes PD-L1 via NEDD4 to control T-cell-mediated bladder cancer immune surveillance. Cancer Research, 82(1), 114–129.

pubmed: 34753771 doi: 10.1158/0008-5472.CAN-21-2362

Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 68(6), 394–424.

pubmed: 30207593

Turnham, D. J., Bullock, N., Dass, M. S., Staffurth, J. N., & Pearson, H. B. (2020, Oct 22). The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells, 9(11), 2342.

pubmed: 33105713 pmcid: 7690430 doi: 10.3390/cells9112342

Dias, A., et al., Prostate cancer germline variations and implications for screening and treatment. Cold Spring Harb Perspect Med, 2018. 8(9).

Hawsawi, Y. M., et al. (2020). Prostate cancer and therapeutic challenges. Journal of Biological Research (Thessaloniki), 27(1), 20.

doi: 10.1186/s40709-020-00128-z

Jordan, V. C., et al. (2016). Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer. Discovery Medicine, 21(117), 411–427.

pubmed: 27355337

Maximov, P. Y., et al. (2018). A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. Endocrine-Related Cancer, 25(2), R83–r113.

pubmed: 29162647 doi: 10.1530/ERC-17-0416

Hawsawi, Y. M., et al. (2018). Stem cell applications for treatment of cancer and autoimmune diseases: Its promises, obstacles, and future perspectives. Technology in Cancer Research & Treatment, 17, 1533033818806910.

doi: 10.1177/1533033818806910

Zielske, S. P., et al. (2023). SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. BMC Cancer, 23(1), 672.

pubmed: 37464317 pmcid: 10353248 doi: 10.1186/s12885-023-11006-x

Kuang, Z., Liu, X., Zhang, N., Dong, J., Sun, C., Yin, M., Wang, Y., Liu, L., Xiao, D., Zhou, X., & Feng, Y. (2023, Oct). USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell Death & Differentiation, 30(10), 2249–2264.

doi: 10.1038/s41418-023-01219-9

Ashrafizadeh, M., et al. (2022). Nanotechnological approaches in prostate cancer therapy: Integration of engineering and biology. Nano Today, 45, 101532.

doi: 10.1016/j.nantod.2022.101532

de Wet, L., et al. (2022). SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene, 41(8), 1190–1202.

pubmed: 35067686 pmcid: 8858874 doi: 10.1038/s41388-021-02157-x

Bhatt, J. R., & Finelli, A. (2014). Landmarks in the diagnosis and treatment of renal cell carcinoma. Nature Reviews. Urology, 11(9), 517–525.

pubmed: 25112856 doi: 10.1038/nrurol.2014.194

Yong, C., Stewart, G. D., & Frezza, C. (2020). Oncometabolites in renal cancer. Nature Reviews. Nephrology, 16(3), 156–172.

pubmed: 31636445 doi: 10.1038/s41581-019-0210-z

Capitanio, U., et al. (2019). Epidemiology of renal cell carcinoma. European Urology, 75(1), 74–84.

pubmed: 30243799 doi: 10.1016/j.eururo.2018.08.036

Itkin, B., Breen, A., Turyanska, L., Sandes, E. O., Bradshaw, T. D., & Loaiza-Perez, A. I. (2020, May 18). New treatments in renal cancer: The AhR ligands. International Journal of Molecular Sciences, 21(10), 3551.

pubmed: 32443455 pmcid: 7279047 doi: 10.3390/ijms21103551

Oto, J., et al. (2020). Urinary microRNAs: Looking for a new tool in diagnosis, prognosis, and monitoring of renal cancer. Current Urology Reports, 21(2), 11.

pubmed: 32166474 doi: 10.1007/s11934-020-0962-9

Greef, B., & Eisen, T. (2016). Medical treatment of renal cancer: New horizons. British Journal of Cancer, 115(5), 505–516.

pubmed: 27490806 pmcid: 4997553 doi: 10.1038/bjc.2016.230

Chai, D., Shi, S. Y., Sobhani, N., Ding, J., Zhang, Z., Jiang, N., Wang, G., Li, M., Li, H., Zheng, J., & Bai, J. (2022, Jun 9). IFI35 promotes renal cancer progression by inhibiting pSTAT1/pSTAT6-dependent autophagy. Cancers, 14(12), 2861.

pubmed: 35740527 pmcid: 9221357 doi: 10.3390/cancers14122861

Marona, P., et al. (2022). Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation. Cell Death & Disease, 13(9), 814.

doi: 10.1038/s41419-022-05251-4

Scatena, R. (2012). Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation. Advances in Experimental Medicine and Biology, 942, 287–308.

pubmed: 22399428 doi: 10.1007/978-94-007-2869-1_13

Nigg, E. A. (1995). Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. Bioessays, 17(6), 471–480.

pubmed: 7575488 doi: 10.1002/bies.950170603

Men, L. J., et al. (2018). Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells. Cancer Cell International, 18, 13.

pubmed: 29422775 pmcid: 5789602 doi: 10.1186/s12935-018-0507-1

Wu, S., et al. (2022). Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis. Cell Biology and Toxicology, 38(1), 129–146.

pubmed: 33656636 doi: 10.1007/s10565-021-09591-3

Yang, C., et al. (2019). Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223/fibroblast growth factor receptor 2 axis. Cancer Science, 110(1), 99–106.

pubmed: 30387298 doi: 10.1111/cas.13857

Zhou, Z., et al. (2020). CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling. The FASEB Journal, 34(6), 7970–7988.

pubmed: 32293074 doi: 10.1096/fj.201902659R

Wu, X., et al. (2019). miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2. Experimental and Therapeutic Medicine, 17(5), 4273–4278.

pubmed: 30988799 pmcid: 6447895

Shi, Y. R., et al. (2020). Circular RNA circKIF4A sponges miR-375/1231 to promote bladder cancer progression by upregulating NOTCH2 expression. Frontiers in Pharmacology, 11, 605.

pubmed: 32457613 pmcid: 7225260 doi: 10.3389/fphar.2020.00605

Duan, F., et al. (2020). Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells. Scientific Reports, 10(1), 7714.

pubmed: 32382009 pmcid: 7206016 doi: 10.1038/s41598-020-64880-x

Li, X., et al. (2022). Gypenoside-induced apoptosis via the PI3K/AKT/mTOR signaling pathway in bladder cancer. BioMed Research International, 2022, 9304552.

pubmed: 35402614 pmcid: 8984741

Chen, Y., et al. (2021). Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway. Bioengineered, 12(2), 11410–11422.

pubmed: 34889689 pmcid: 8810167 doi: 10.1080/21655979.2021.2008738

Huang, J., et al. (2019). Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. Journal of Experimental & Clinical Cancer Research, 38(1), 138.

doi: 10.1186/s13046-019-1146-7

Oliemuller, E., Newman, R., Tsang, S. M., Foo, S., Muirhead, G., Noor, F., Haider, S., Aurrekoetxea-Rodríguez, I., Vivanco, M. D., & Howard, B. A. (2020, Sep). SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. Elife, 10(9), e58374.

doi: 10.7554/eLife.58374

Wu, Z., et al. (2018). Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11. Molecular Medicine, 24(1), 40.

pubmed: 30134837 pmcid: 6069875 doi: 10.1186/s10020-018-0039-0

Zhou, M., et al. (2020). KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p. International Journal of Biological Sciences, 16(12), 2063–2071.

pubmed: 32549754 pmcid: 7294933 doi: 10.7150/ijbs.45999

Yeh, C. M., Lee, Y. J., Ko, P. Y., Lin, Y. M., & Sung, W. W. (2021, Jan). High expression of KLF10 is associated with favorable survival in patients with oral squamous cell carcinoma. Medicina, 57(1), 17.

doi: 10.3390/medicina57010017

He, Q., et al. (2020). circRNA circFUT8 upregulates Krüpple-like factor 10 to inhibit the metastasis of bladder cancer via sponging miR-570-3p. Molecular Therapy Oncolytics, 16, 172–187.

pubmed: 32072011 pmcid: 7013148 doi: 10.1016/j.omto.2019.12.014

Dong, W., et al. (2019). Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Molecular Cancer, 18(1), 95.

pubmed: 31101108 pmcid: 6524247 doi: 10.1186/s12943-019-1025-z

Liu, J., et al. (2021). Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway. Drug Development Research, 82(2), 278–286.

pubmed: 33112006 doi: 10.1002/ddr.21751

Xu, H., et al. (2021). E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death & Disease, 12(3), 239.

doi: 10.1038/s41419-021-03521-1

Man, X., et al. (2019). USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. Journal of Experimental & Clinical Cancer Research, 38(1), 259.

doi: 10.1186/s13046-019-1262-4

Tian, Y., et al. (2021). Circular RNA circSETD3 hampers cell growth, migration, and stem cell properties in bladder cancer through sponging miR-641 to upregulate PTEN. Cell Cycle, 20(16), 1589–1602.

pubmed: 34288821 pmcid: 8409755 doi: 10.1080/15384101.2021.1954758

Lu, Q., et al. (2019). Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Molecular Cancer, 18(1), 111.

pubmed: 31228937 pmcid: 6588875 doi: 10.1186/s12943-019-1040-0

Mirzaei, S., et al. (2023). Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression. Environmental Research, 231, 116115.

pubmed: 37178752 doi: 10.1016/j.envres.2023.116115

Guo, Z., Ashrafizadeh, M., Zhang, W., Zou, R., Sethi, G., & Zhang, X. (2023, Jul). Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: A pre-clinical connection to aggressiveness and drug resistance. Cancer and Metastasis Reviews, 15, 1–25.

Xu, N., et al. (2020). Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity. Journal of Cancer, 11(22), 6633–6641.

pubmed: 33046984 pmcid: 7545671 doi: 10.7150/jca.47025

Liu, X., et al. (2019). CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells. Molecular Medicine Reports, 19(3), 1678–1686.

pubmed: 30592282

Li, Y., et al. (2019). Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition. Biochemical and Biophysical Research Communications, 508(4), 991–996.

pubmed: 30551873 doi: 10.1016/j.bbrc.2018.12.046

Wang, Y., et al. (2023). DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. Nature Communications, 14(1), 2421.

pubmed: 37105989 pmcid: 10140023 doi: 10.1038/s41467-023-38160-x

Chen, S., et al. (2022). HOXA1 promotes proliferation and metastasis of bladder cancer by enhancing SMAD3 transcription. Pathology, Research and Practice, 239, 154141.

pubmed: 36228347 doi: 10.1016/j.prp.2022.154141

Zhang, Y., et al. (2023). circSOBP inhibits bladder cancer proliferation and metastasis by regulating the miR-200a-3p/PTEN axis and participating in the immune response. Cell Transplantation, 32, 9636897231165874.

pubmed: 37026617 doi: 10.1177/09636897231165874

He, P., Dai, Q., & Wu, X. (2023, Mar). New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials. Environmental Research, 10, 115672.

doi: 10.1016/j.envres.2023.115672

Alqurashi, Y. E., Al-Hetty, H. R., Ramaiah, P., Fazaa, A. H., Jalil, A. T., Alsaikhan, F., Gupta, J., Ramírez-Coronel, A. A., Tayyib, N. A., & Peng, H. (2023, Mar). Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environmental Research, 17, 115683.

doi: 10.1016/j.envres.2023.115683

Saleem, H. M., Ramaiah, P., Gupta, J., Jalil, A. T., Kadhim, N. A., Alsaikhan, F., Ramírez-Coronel, A. A., Tayyib, N. A., & Guo, Q. (2023, Apr). Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nano engineered structures for modulating growth and metastasis. Environmental Research, 18, 115942.

doi: 10.1016/j.envres.2023.115942

Sahib, A. S., et al. (2023). miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers. Cellular Signalling, 112, 110881.

pubmed: 37666286 doi: 10.1016/j.cellsig.2023.110881

Ma, X., et al. (2021). circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discov, 7(1), 365.

pubmed: 34811353 pmcid: 8608878 doi: 10.1038/s41420-021-00712-9

Li, Y., et al. (2023). ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research, 42(1), 191.

doi: 10.1186/s13046-023-02757-3

Tan, S., et al. (2021). circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis. Cell Death & Disease, 12(2), 168.

doi: 10.1038/s41419-021-03459-4

Ren, L., et al. (2022). Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway. International Journal of Biological Sciences, 18(13), 5207–5220.

pubmed: 35982887 pmcid: 9379395 doi: 10.7150/ijbs.69373

Liu, F., et al. (2020). Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis. Oncogene, 39(8), 1696–1709.

pubmed: 31705065 doi: 10.1038/s41388-019-1092-z

Liu, F., et al. (2021). Circ_0006948 drives the malignant development of bladder cancer via activating the epithelial-mesenchymal transition. Journal of BUON, 26(4), 1491–1497.

pubmed: 34565009

Yuan, W., et al. (2019). Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition. Molecular Oncology, 13(7), 1559–1576.

pubmed: 31131537 pmcid: 6599840 doi: 10.1002/1878-0261.12523

Bissey, P. A., et al. (2020). MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer, 20(1), 597.

pubmed: 32586280 pmcid: 7318489 doi: 10.1186/s12885-020-07081-z

Cao, W., et al. (2022). HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis. Bioengineered, 13(3), 6567–6578.

pubmed: 35227173 pmcid: 8975274 doi: 10.1080/21655979.2022.2038429

Zhu, J., & Zhang, F. (2021). Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells. Open Med (Wars), 16(1), 1010–1021.

pubmed: 34258391 doi: 10.1515/med-2021-0299

Huang, W., et al. (2020). Circular RNA circRNA_103809 accelerates bladder cancer progression and enhances chemo-resistance by activation of miR-516a-5p/FBXL18 axis. Cancer Management and Research, 12, 7561–7568.

pubmed: 32922071 pmcid: 7457878 doi: 10.2147/CMAR.S263083

Xie, F., et al. (2020). Circular RNA CircHIPK3 promotes gemcitabine sensitivity in bladder cancer. Journal of Cancer, 11(7), 1907–1912.

pubmed: 32194801 pmcid: 7052855 doi: 10.7150/jca.39722

Tang, G., et al. (2017). Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer. International Journal of Clinical and Experimental Pathology, 10(8), 8495–8502.

pubmed: 31966702 pmcid: 6965445

Yan, D., et al. (2019). Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation. EBioMedicine, 48, 316–331.

pubmed: 31648990 pmcid: 6838432 doi: 10.1016/j.ebiom.2019.08.074

Xu, Z. Q., et al. (2018). Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells. Journal of Cellular Biochemistry, 119(4), 3317–3325.

pubmed: 29125888 doi: 10.1002/jcb.26492

Zhuang, C., et al. (2020). Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1. BMB Reports, 53(2), 82–87.

pubmed: 31072448 pmcid: 7061208 doi: 10.5483/BMBRep.2020.53.2.059

Yang, D., et al. (2020). Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis. Cancer Medicine, 9(2), 700–710.

pubmed: 31758655 doi: 10.1002/cam4.2650

Zhang, X., et al. (2022). Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p. Bioengineered, 13(4), 8823–8835.

pubmed: 35358000 pmcid: 9161836 doi: 10.1080/21655979.2022.2054753

Wu, S., et al. (2022). Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA. Mol Ther Oncolytics, 24, 742–754.

pubmed: 35317525 pmcid: 8908064 doi: 10.1016/j.omto.2022.02.020

Feng, L., et al. (2021). Circular RNA_0001495 increases Robo1 expression by sponging microRNA-527 to promote the proliferation, migration and invasion of bladder cancer cells. Carcinogenesis, 42(8), 1046–1055.

pubmed: 34021307 doi: 10.1093/carcin/bgab040

Jiang, Y., et al. (2019). Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p. American Journal of Translational Research, 11(3), 1644–1652.

pubmed: 30972190 pmcid: 6456557

Liu, T., et al. (2020). Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762. Cell Death & Disease, 11(1), 47.

doi: 10.1038/s41419-020-2226-5

Wang, F., et al. (2021). Circular RNA CircPPP1CB suppresses tumorigenesis by interacting with the MiR-1307-3p/SMG1 axis in human bladder cancer. Frontiers in Cell and Development Biology, 9, 704683.

doi: 10.3389/fcell.2021.704683

Liu, H., et al. (2018). Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer. Aging (Albany NY), 10(10), 2606–2623.

pubmed: 30312173 pmcid: 6224258 doi: 10.18632/aging.101573

Yang, C., et al. (2021). High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis. Cell Death & Disease, 12(8), 719.

doi: 10.1038/s41419-021-03977-1

Zuo, L., et al. (2022). Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway. Aging (Albany NY), 14(4), 1891–1909.

pubmed: 35200157 doi: 10.18632/aging.203911

Zhong, Z., et al. (2017). Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Letters, 403, 305–317.

pubmed: 28687357 doi: 10.1016/j.canlet.2017.06.027

Wang, L., Wu, S., He, H., Ai, K., Xu, R., Zhang, L., & Zhu, X. (2022, Dec). CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis. Laboratory Investigation, 102(12), 1323–1334.

pubmed: 35945269 doi: 10.1038/s41374-022-00826-3

Liu, Z., et al. (2020). Novel circRNA_0071196/miRNA-19b-3p/CIT axis is associated with proliferation and migration of bladder cancer. International Journal of Oncology, 57(3), 767–779.

pubmed: 32705161 pmcid: 7384843 doi: 10.3892/ijo.2020.5093

Peng, G., et al. (2021). CircRNA 001418 promoted cell growth and metastasis of bladder carcinoma via EphA2 by miR-1297. Current Molecular Pharmacology, 14(1), 68–78.

pubmed: 32368989 doi: 10.2174/1874467213666200505093815

Yang, J., et al. (2022). Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p. Cell Death & Disease, 13(4), 322.

doi: 10.1038/s41419-022-04732-w

Fu, Y., et al. (2023). Circular RNA Ubiquitin-associated protein 2 silencing suppresses bladder cancer progression by downregulating DNA topoisomerase 2-alpha through sponging miR-496. Eur Urol Open Sci, 50, 31–42.

pubmed: 37101770 pmcid: 10123418 doi: 10.1016/j.euros.2023.01.008

Ju, M., et al. (2023). Downregulation of circular RNA hsa_circ_0087856 sensitizes bladder cancer cells to cisplatin through targeting miR-1184/CITED2 signaling. Environmental and Molecular Mutagenesis, 64(6), 342–353.

pubmed: 37392146 doi: 10.1002/em.22561

Fang, P., et al. (2022). Circ_0002099 is a novel molecular therapeutic target for bladder cancer. Drug Development Research, 83(8), 1890–1905.

pubmed: 36301978 doi: 10.1002/ddr.22005

Zhou, H., Huang, J., & Wang, F. (2023). Increased transcription of hsa_circ_0000644 upon RUNX family transcription factor 3 downregulation participates in the malignant development of bladder cancer. Cellular Signalling, 104, 110590.

pubmed: 36627006 doi: 10.1016/j.cellsig.2023.110590

Liu, Q., et al. (2022). Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling. Cancer Gene Therapy, 29(12), 1988–2000.

pubmed: 35915245 pmcid: 9750871 doi: 10.1038/s41417-022-00506-w

Liu, S., et al. (2022). Effects of circFOXO3 on the proliferation and invasion of liver cancer cells by regulating PI3K/Akt pathway. Contrast Media & Molecular Imaging, 2022, 2109908.

Xiang, T., et al. (2020). CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44. Gene, 753, 144798.

pubmed: 32445925 doi: 10.1016/j.gene.2020.144798

Huang, W., Huang, F., & Feng, C. (2020). CircFoxo3 promotes adriamycin resistance through regulation of miR-199a-5p/ATP binding cassette subfamily C member 1 axis in hepatocellular carcinoma. Oncotargets and Therapy, 13, 5113–5122.

pubmed: 32606732 pmcid: 7292492 doi: 10.2147/OTT.S243571

Kong, Z., et al. (2020). Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. Journal of Cellular and Molecular Medicine, 24(1), 799–813.

pubmed: 31733095 doi: 10.1111/jcmm.14791

Ren, K., et al. (2019). Pim-2 Cooperates with downstream factor XIAP to inhibit apoptosis and intensify malignant grade in prostate cancer. Pathology Oncology Research, 25(1), 341–348.

pubmed: 29124675 doi: 10.1007/s12253-017-0353-9

Yin, S., et al. (2022). PP2A promotes apoptosis and facilitates docetaxel sensitivity via the PP2A/p-eIF4B/XIAP signaling pathway in prostate cancer. Oncology Letters, 23(3), 101.

pubmed: 35154432 pmcid: 8822497 doi: 10.3892/ol.2022.13221

Niu, Y., et al. (2021). Effect of the circCDR1as/miR-641/XIAP regulatory axis on the proliferation and invasion of the prostate cancer PC-3 cell line. Oncology Letters, 21(6), 469.

pubmed: 33907579 pmcid: 8063307 doi: 10.3892/ol.2021.12730

Feng, Y., et al. (2019). Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death & Disease, 10(11), 792.

doi: 10.1038/s41419-019-2028-9

Zhang, Z. H., Liu, M. D., Yao, K., Xu, S., Yu, D. X., Xie, D. D., & Xu, D. X. (2023, Jan). Vitamin D deficiency aggravates growth and metastasis of prostate cancer through promoting EMT in two β-catenin-related mechanisms. The Journal of Nutritional Biochemistry, 1(111), 109177.

doi: 10.1016/j.jnutbio.2022.109177

Liu, C. M., et al. (2022). 6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS-stimulated and LPS-unstimulated prostate cancer cells. Oncology Letters, 23(6), 187.

pubmed: 35527779 pmcid: 9073581 doi: 10.3892/ol.2022.13307

Mao, Y., et al. (2020). Circular RNA_PDHX promotes the proliferation and invasion of prostate cancer by sponging MiR-378a-3p. Frontiers in Cell and Development Biology, 8, 602707.

doi: 10.3389/fcell.2020.602707

Yang, D., et al. (2021). Circular RNA-DPP4 serves an oncogenic role in prostate cancer progression through regulating miR-195/cyclin D1 axis. Cancer Cell International, 21(1), 379.

pubmed: 34271919 pmcid: 8283928 doi: 10.1186/s12935-021-02062-z

Peng, Y., et al. (2022). Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc. Cell Death and Differentiation, 29(9), 1730–1743.

pubmed: 35217790 pmcid: 9433443 doi: 10.1038/s41418-022-00960-x

Jiang, X., et al. (2022). TFAP2C-mediated lncRNA PCAT1 inhibits ferroptosis in docetaxel-resistant prostate cancer through c-Myc/miR-25-3p/SLC7A11 signaling. Frontiers in Oncology, 12, 862015.

pubmed: 35402284 pmcid: 8985761 doi: 10.3389/fonc.2022.862015

Ding, T., et al. (2021). Circular RNA circ_0057558 controls prostate cancer cell proliferation through regulating miR-206/USP33/c-Myc axis. Frontiers in Cell and Development Biology, 9, 644397.

doi: 10.3389/fcell.2021.644397

Cai, J., et al. (2022). Patchouli alcohol suppresses castration-resistant prostate cancer progression by inhibiting NF-κB signal pathways. Transl Androl Urol, 11(4), 528–542.

pubmed: 35558260 pmcid: 9085927 doi: 10.21037/tau-22-220

Tian, H. Y., et al. (2022). Exosomal CXCL14 contributes to M2 macrophage polarization through NF-κB signaling in prostate cancer. Oxidative Medicine and Cellular Longevity, 2022, 7616696.

pubmed: 35669852 pmcid: 9166984 doi: 10.1155/2022/7616696

Chen, W., et al. (2020). Circular RNA CircNOLC1, upregulated by NF-KappaB, promotes the progression of prostate cancer via miR-647/PAQR4 axis. Frontiers in Cell and Development Biology, 8, 624764.

doi: 10.3389/fcell.2020.624764

Adissu, H. A., et al. (2015). Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer. Prostate, 75(16), 1831–1843.

pubmed: 26332574 doi: 10.1002/pros.23056

Wang, X., et al. (2018). Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. Journal of BUON, 23(2), 444–452.

pubmed: 29745091

Xie, X., et al. (2021). A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the miR-181b-5p/miR-17-3p-TIMP3 axis. Aging (Albany NY), 13(15), 19908–19919.

pubmed: 34390329 doi: 10.18632/aging.203408

Li, R., Quan, Y., & Xia, W. (2018). SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway. Experimental Cell Research, 364(2), 143–151.

pubmed: 29421536 doi: 10.1016/j.yexcr.2018.01.036

Qiu, X., & Dou, Y. (2017). miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A. Biomedicine & Pharmacotherapy, 88, 430–435.

doi: 10.1016/j.biopha.2016.11.120

Weng, X. D., Yan, T., & Liu, C. L. (2020). Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A. European Review for Medical and Pharmacological Sciences, 24(10), 5303–5309.

pubmed: 32495863

Lu, X., et al. (2022). HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature Genetics, 54(5), 670–683.

pubmed: 35468964 pmcid: 9117466 doi: 10.1038/s41588-022-01045-8

Wang, X., et al. (2019). Circular RNA ITCH suppressed prostate cancer progression by increasing HOXB13 expression via spongy miR-17-5p. Cancer Cell International, 19, 328.

pubmed: 31827402 pmcid: 6892157 doi: 10.1186/s12935-019-0994-8

Belair, C. D., et al. (2015). DGCR8 is essential for tumor progression following PTEN loss in the prostate. EMBO Reports, 16(9), 1219–1232.

pubmed: 26206718 pmcid: 4576988 doi: 10.15252/embr.201439925

Dong, J. S., Wu, B., & Chen, X. H. (2020). Circ PSMC3 inhibits prostate cancer cell proliferation by downregulating DGCR8. European Review for Medical and Pharmacological Sciences, 24(5), 2264–2270.

pubmed: 32196577

Zhang, Y., Liu, F., Feng, Y., Xu, X., Wang, Y., Zhu, S., Dong, J., Zhao, S., Xu, B., & Feng, N. (2022, Nov). CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9. Cancer Gene Therapy, 29(11), 1731–1741.

pubmed: 35760899 pmcid: 9663304 doi: 10.1038/s41417-022-00492-z

Zhang, G., et al. (2022). Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR-1/MAP 3 K1 axis. The Journal of Gene Medicine, 24(8), e3376.

pubmed: 34191363 doi: 10.1002/jgm.3376

Wang, P., et al. (2021). hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis. Acta Biochimica et Biophysica Sinica Shanghai, 53(7), 815–822.

doi: 10.1093/abbs/gmab058

Zhang, S., et al. (2020). Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis. Experimental Cell Research, 395(2), 112233.

pubmed: 32810511 doi: 10.1016/j.yexcr.2020.112233

Li, Q., et al. (2020). Circular RNA circ-0016068 promotes the growth, migration, and invasion of prostate cancer cells by regulating the miR-330-3p/BMI-1 axis as a competing endogenous RNA. Frontiers in Cell and Development Biology, 8, 827.

doi: 10.3389/fcell.2020.00827

Yi, X., et al. (2023). Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway. Journal of Cellular and Molecular Medicine, 27(3), 403–411.

pubmed: 36625246 pmcid: 9889667 doi: 10.1111/jcmm.17663

Li, W., et al. (2022). Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways. Pharmaceutical Biology, 60(1), 1865–1875.

pubmed: 36205544 pmcid: 9553173 doi: 10.1080/13880209.2022.2123931

Shi, J., et al. (2020). Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis. Aging (Albany NY), 12(13), 13255–13280.

pubmed: 32645691 doi: 10.18632/aging.103432

Luo, G. C., et al. (2021). Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling. Bioengineered, 12(2), 11089–11107.

pubmed: 34852706 pmcid: 8810173 doi: 10.1080/21655979.2021.2008217

Ren, X., et al. (2022). Circular RNA circ_0062019 exerts oncogenic properties in prostate cancer via mediating miR-1253/NRBP1 axis. Andrologia, 54(3), e14343.

pubmed: 34866220 doi: 10.1111/and.14343

Shen, Z., et al. (2020). Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Letters, 468, 88–101.

pubmed: 31593800 doi: 10.1016/j.canlet.2019.10.006

Gao, Y., et al. (2020). Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7. Cancer Cell International, 20, 334.

pubmed: 32714093 pmcid: 7376840 doi: 10.1186/s12935-020-01421-6

Chen, L., et al. (2022). Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. Journal of Experimental & Clinical Cancer Research, 41(1), 194.

doi: 10.1186/s13046-022-02404-3

Li, R., Luo, S., & Zhang, D. (2020). Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway. Gene, 754, 144811.

pubmed: 32464246 doi: 10.1016/j.gene.2020.144811

Li, P., et al. (2021). Disruption of SND1-MTDH interaction by a high affinity peptide results in SND1 degradation and cytotoxicity to breast cancer cells in vitro and in vivo. Molecular Cancer Therapeutics, 20(1), 76–84.

pubmed: 33268570 doi: 10.1158/1535-7163.MCT-20-0130

Chen, L., et al. (2022). High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling. Cell Death Discov, 8(1), 128.

pubmed: 35318303 pmcid: 8941094 doi: 10.1038/s41420-022-00898-6

Shi, Q., et al. (2022). SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer. Cell Death and Differentiation, 29(6), 1228–1239.

pubmed: 34987184 pmcid: 9177840 doi: 10.1038/s41418-021-00913-w

Xing, Z., et al. (2021). CircSERPINA3 regulates SERPINA3-mediated apoptosis, autophagy and aerobic glycolysis of prostate cancer cells by competitively binding to MiR-653-5p and recruiting BUD13. Journal of Translational Medicine, 19(1), 492.

pubmed: 34861864 pmcid: 8642898 doi: 10.1186/s12967-021-03063-2

Shi, Y. X., et al. (2022). Autophagy deficiency promotes lung metastasis of prostate cancer via stabilization of TWIST1. Clinical & Translational Oncology, 24(7), 1403–1412.

doi: 10.1007/s12094-022-02786-y

Yu, Y., et al. (2022). CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. Journal of Experimental & Clinical Cancer Research, 41(1), 188.

doi: 10.1186/s13046-022-02381-7

Niture, S., et al. (2022). MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. Tumour Biology, 44(1), 107–127.

pubmed: 35811549 doi: 10.3233/TUB-211568

Yu, Y., et al. (2022). ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death & Disease, 13(1), 46.

doi: 10.1038/s41419-021-04494-x

Huang, E., Chen, X., & Yuan, Y. (2019). Downregulated circular RNA itchy E3 ubiquitin protein ligase correlates with advanced pathologic T stage, high lymph node metastasis risk and poor survivals in prostate cancer patients. Cancer Biomarkers, 26(1), 41–50.

pubmed: 31306101 doi: 10.3233/CBM-182111

Liu, D. C., et al. (2021). Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling. Clinical & Translational Oncology, 23(12), 2497–2506.

doi: 10.1007/s12094-021-02650-5

Si-Tu, J., et al. (2019). Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. International Journal of Biological Macromolecules, 122, 1235–1243.

pubmed: 30219508 doi: 10.1016/j.ijbiomac.2018.09.076

Li, X., et al. (2021). Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis. Oncology Letters, 21(6), 486.

pubmed: 33968202 pmcid: 8100954 doi: 10.3892/ol.2021.12747

Han, Y., et al. (2021). Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells. Bioengineered, 12(1), 5620–5631.

pubmed: 34515615 pmcid: 8806842 doi: 10.1080/21655979.2021.1967064

Tao, L. J., et al. (2021). Circular RNA circANKS1B acts as a sponge for miR-152-3p and promotes prostate cancer progression by upregulating TGF-α expression. Prostate, 81(5), 271–278.

pubmed: 33556191 doi: 10.1002/pros.24102

Huang, C., et al. (2019). Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression. Journal of Cellular and Molecular Medicine, 23(9), 6112–6119.

pubmed: 31270953 pmcid: 6714494 doi: 10.1111/jcmm.14477

Chao, F., et al. (2021). Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p/MYPT1/p-MLC2 axis in prostate cancer. Clinical and Translational Medicine, 11(3), e360.

pubmed: 33784000 pmcid: 8002909 doi: 10.1002/ctm2.360

Kong, Z., et al. (2017). Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. Biochemical and Biophysical Research Communications, 493(3), 1217–1223.

pubmed: 28765045 doi: 10.1016/j.bbrc.2017.07.162

Jin, C., et al. (2019). Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer. Artif Cells Nanomed Biotechnol, 47(1), 3350–3358.

pubmed: 31387394 doi: 10.1080/21691401.2019.1648281

Deng, W., et al. (2022). Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer. Cancer Letters, 533, 215606.

pubmed: 35227787 doi: 10.1016/j.canlet.2022.215606

Tao, W., et al. (2023). Plasma extracellular vesicle circRNA signature and resistance to abiraterone in metastatic castration-resistant prostate cancer. British Journal of Cancer, 128(7), 1320–1332.

pubmed: 36703078 doi: 10.1038/s41416-023-02147-8

Lv, D., et al. (2023). Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis. Cell Cycle, 22(9), 1101–1115.

pubmed: 36740902 pmcid: 10081070 doi: 10.1080/15384101.2023.2174658

Yu, T., Du, H., & Sun, C. (2023). Circ-ABCC4 contributes to prostate cancer progression and radioresistance by mediating miR-1253/SOX4 cascade. Anti-Cancer Drugs, 34(1), 155–165.

pubmed: 36539368 doi: 10.1097/CAD.0000000000001361

Yin, Z., et al. (2023). Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p/SEPT2 axis. Pathology, Research and Practice, 243, 154317.

pubmed: 36738516 doi: 10.1016/j.prp.2023.154317

Li, W., & Wu, W. (2023). Circ_0005276 promotes prostate cancer progression through the crosstalk of miR-128-3p/DEPDC1B axis. Biochemical Genetics, 61(5), 1987–2003.

pubmed: 36913076 doi: 10.1007/s10528-022-10328-y

Zhang, P., et al. (2023). has_circ_0070512 promotes prostate cancer progression by regulating the miR-338-3p/hedgehog signaling pathway. Cancer Science, 114(4), 1491–1506.

pubmed: 36411517 doi: 10.1111/cas.15672

Cao, C., et al. (2023). The circular RNA Circ_0085494 regulates prostate cancer progression through NRBP1/miR-497-5p axis. Biochemical Genetics, 61(5), 1775–1790.

pubmed: 36790665 doi: 10.1007/s10528-023-10341-9

Zhang, Y., et al. (2023). Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3. Carcinogenesis, 44(1), 15–28.

pubmed: 36394342 doi: 10.1093/carcin/bgac091

Guo, K., et al. (2023). Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR-671-5p/LGALS3BP/NF-κB axis. Cancer Science, 114(7), 2907–2919.

pubmed: 37186007 pmcid: 10323094 doi: 10.1111/cas.15820

Chen, Y. Y., Luo, L. P., & Deng, K. C. (2023). Circular RNA LPAR3 targets JPT1 via microRNA-513b-5p to facilitate glycolytic activation but repress prostate cancer radiosensitivity. Acta Biochimica Polonica, 70(1), 153–162.

pubmed: 36929708

Pei, L., Song, X., Liang, X., Li, M., Zhang, A., & Tan, X. (2023, Apr). Circular RNA dipeptidyl peptidase 4 (circDPP4) stimulates the expression of glutamate dehydrogenase 1 to contribute to the malignant phenotypes of prostate cancer by sponging miR-497-5p. Molecular Biotechnology, 20, 1–3.

Yan, J. S., et al. (2021). Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis. Cell Cycle, 20(23), 2519–2530.

pubmed: 34705617 pmcid: 8794523 doi: 10.1080/15384101.2021.1991123

Jin, C., et al. (2019). Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22. American Journal of Translational Research, 11(8), 4935–4945.

pubmed: 31497210 pmcid: 6731413

Li, X., et al. (2021). miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2. International Journal of Biological Sciences, 17(15), 4327–4339.

pubmed: 34803501 pmcid: 8579463 doi: 10.7150/ijbs.64851

Jiang, T., & Cheng, H. (2021). miR-34a-5p blocks cervical cancer growth and migration by downregulating CDC25A. Journal of BUON, 26(5), 1768–1774.

pubmed: 34761581

Li, Y., et al. (2015). microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression. Cell Proliferation, 48(6), 643–649.

pubmed: 26597380 pmcid: 6496530 doi: 10.1111/cpr.12223

Li, Z., et al. (2022). IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. International Journal of Biological Sciences, 18(1), 30–42.

pubmed: 34975316 pmcid: 8692136 doi: 10.7150/ijbs.65255

Lin, L., & Cai, J. (2020). Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation. Journal of Cellular Biochemistry, 121(11), 4377–4385.

pubmed: 31904147 doi: 10.1002/jcb.29620

Cheng, W. K., et al. (2022). Downregulation of Manic fringe impedes angiogenesis and cell migration of renal carcinoma. Microvascular Research, 142, 104341.

pubmed: 35157839 doi: 10.1016/j.mvr.2022.104341

Wang, N., et al. (2022). Calbindin S100A16 promotes renal cell carcinoma progression and angiogenesis via the VEGF/VEGFR2 signaling pathway. Contrast Media & Molecular Imaging, 2022, 5602011.

doi: 10.1155/2022/5602011

Hou, P., et al. (2019). PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway. Angiogenesis, 22(4), 507–519.

pubmed: 31254127 doi: 10.1007/s10456-019-09675-z

Ou, Y., et al. (2022). Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1/miR-374b-3p/VEGFA signaling axis. Cell Death Discov, 8(1), 68.

pubmed: 35173146 pmcid: 8850424 doi: 10.1038/s41420-022-00865-1

Pan, X., et al. (2022). Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clinical and Translational Medicine, 12(7), e994.

pubmed: 35876041 pmcid: 9309750 doi: 10.1002/ctm2.994

Chen, M., et al. (2019). circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893. Biomedicine & Pharmacotherapy, 117, 109064.

doi: 10.1016/j.biopha.2019.109064

Wang, P., et al. (2021). circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways. Oncology Letters, 22(1), 563.

pubmed: 34113391 pmcid: 8185704 doi: 10.3892/ol.2021.12824

Li, K., Wan, C. L., & Guo, Y. (2020). Circular RNA circMTO1 suppresses RCC cancer cell progression via miR9/LMX1A axis. Technology in Cancer Research & Treatment, 19, 1533033820914286.

doi: 10.1177/1533033820914286

Wang, Y., et al. (2022). Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis. International Journal of Biological Sciences, 18(4), 1491–1507.

pubmed: 35280687 pmcid: 8898370 doi: 10.7150/ijbs.69351

Wu, X., et al. (2022). CircCYP24A1 hampered malignant phenotype of renal cancer carcinoma through modulating CMTM-4 expression via sponging miR-421. Cell Death & Disease, 13(2), 190.

doi: 10.1038/s41419-022-04623-0

Wang, W., et al. (2021). Systematic review with meta-analysis: Diagnostic, prognostic and clinicopathological significance of CircRNA expression in renal cancer. Frontiers in Oncology, 11, 773236.

pubmed: 35155185 doi: 10.3389/fonc.2021.773236

Stadler, W. M., et al. (2006). A phase II study of gemcitabine and capecitabine in metastatic renal cancer: A report of Cancer and Leukemia Group B protocol 90008. Cancer, 107(6), 1273–1279.

pubmed: 16909426 doi: 10.1002/cncr.22117

Zustovich, F., et al. (2007). A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancer. Anticancer Research, 27(6c), 4461–4464.

pubmed: 18214061

Qin, Y., Ashrafizadeh, M., Mongiardini, V., Grimaldi, B., Crea, F., Rietdorf, K., Győrffy, B., Klionsky, D. J., Ren, J., Zhang, W., & Zhang, X. (2023, Jul). Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence. Cancer Letters, 12, 216307.

doi: 10.1016/j.canlet.2023.216307

Ashrafizadeh, M., et al. (2023). A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk. Pharmacological Research, 194, 106822.

pubmed: 37336429 doi: 10.1016/j.phrs.2023.106822

Yin, H., et al. (2017). HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation. Oncotarget, 8(42), 71642–71656.

pubmed: 29069735 pmcid: 5641078 doi: 10.18632/oncotarget.17796

Chen, X., et al. (2021). Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis. Theranostics, 11(18), 8692–8705.

pubmed: 34522207 pmcid: 8419034 doi: 10.7150/thno.60437

Yan, L., et al. (2019). Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation. Biochemical and Biophysical Research Communications, 519(1), 172–178.

pubmed: 31492499 doi: 10.1016/j.bbrc.2019.08.093

Wu, Z., et al. (2020). Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis. BMC Pulmonary Medicine, 20(1), 10.

pubmed: 31931771 pmcid: 6958770 doi: 10.1186/s12890-019-1035-z

Wang, G., et al. (2018). The effect of Hsa_circ_0001451 in clear cell renal cell carcinoma cells and its relationship with clinicopathological features. Journal of Cancer, 9(18), 3269–3277.

pubmed: 30271486 pmcid: 6160682 doi: 10.7150/jca.25902

Liu, Z., Wang, R., & Zhu, G. (2021). Circ_0035483 functions as a tumor promoter in renal cell carcinoma via the miR-31-5p-mediated HMGA1 upregulation. Cancer Management and Research, 13, 693–706.

pubmed: 33531839 pmcid: 7846871 doi: 10.2147/CMAR.S282806

Shen, S., Jiang, M., Deng, W., Liu, X., Xiong, J., Zeng, Z., Zhao, H., Zeng, X., & Fu, B. (2022). Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217. The Journal of Gene Medicine, 24(11), e3418.

pubmed: 35357059 doi: 10.1002/jgm.3418

Pei, L., et al. (2022). Circular RNA circSDHC (hsa_circ_0015004) regulates tumor growth and angiogenesis via regulating centrosomal protein 55 expression in renal cell carcinoma. Histology and Histopathology, 18467.

Chen, Z., et al. (2021). Identification of hsa_circ_0002024 as a prognostic competing endogenous RNA (ceRNA) through the hsa_miR_129-5p/Anti-Silencing Function 1B Histone Chaperone (ASF1B) axis in renal cell carcinoma. Bioengineered, 12(1), 6579–6593.

pubmed: 34516341 pmcid: 8806722 doi: 10.1080/21655979.2021.1974650

Cen, J., et al. (2021). Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis. Molecular Cancer, 20(1), 19.

pubmed: 33468140 pmcid: 7816303 doi: 10.1186/s12943-021-01314-w

Xu, Z., et al. (2022). Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway. Molecular Cancer, 21(1), 146.

pubmed: 35840930 pmcid: 9284792 doi: 10.1186/s12943-022-01607-8

Yang, C. Y., et al. (2021). Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway. Bioengineered, 12(1), 4432–4441.

pubmed: 34308775 pmcid: 8806623 doi: 10.1080/21655979.2021.1955579

Xiong, Y., Zhang, J., & Song, C. (2019). CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. Journal of Cellular Physiology, 234(7), 10646–10654.

pubmed: 30478938 doi: 10.1002/jcp.27744

Du, C., Yan, Q., Wang, Y., Ren, L., Lu, H., Han, M., Wu, Y., Wang, Y., & Ye, M. (2023, May). Circular RNA AGAP1 stimulates immune escape and distant metastasis in renal cell carcinoma. Molecular Biotechnology, 18, 1–3.

Xu, Y. Y., et al. (2023). Read-through circular RNA rt-circ-HS promotes hypoxia inducible factor 1α expression and renal carcinoma cell proliferation, migration and invasiveness. Beijing Da Xue Xue Bao. Yi Xue Ban, 55(2), 217–227.

pubmed: 37042131

Fang, K., Liang, S., Liu, D., Yi, Q., Li, Y., & Zhu, R. (2023, Jun). Hsa_circ_0003596 enhances the development of cell renal clear cell carcinoma through the miR-502-5p/IGF1/PI3K/AKT axis. The Journal of Gene Medicine, 30, e3562.

doi: 10.1002/jgm.3562

Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Zhibin Zhang (Z)

Zhixu Gao (Z)

Huimin Fang (H)

Yutang Zhao (Y)

Rong Xing (R)

Classifications MeSH